[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
[ Wed, Oct 02nd 2024 ]: WOPRAI
Kemp Dolliver Downgraded (VRCA) to Hold on, Oct 2nd, 2024
Kemp Dolliver of Brookline Capital, Downgraded "Verrica Pharmaceuticals Inc." (VRCA) to Hold on, Oct 2nd, 2024.
Kemp has made no other calls on VRCA in the last 4 months.
There are 2 other peers that have a rating on VRCA. Out of the 2 peers that are also analyzing VRCA, 0 agree with Kemp's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Kemp
- Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $13 on, Thursday, August 15th, 2024
- Serge Belanger of "Needham" Maintained at Strong Buy with Decreased Target to $12 on, Thursday, August 15th, 2024